---
schema_version: "secwatch.filing_event.v1"
accession: "0001156039-25-000096"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2025-05-28T23:59:59+00:00"
generated_at: "2026-05-20T07:33:20.801505+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Elevance reaffirms FY2025 adjusted EPS guidance of $34.15-$34.85

## Summary
- FY2025 GAAP EPS guidance $28.30-$29.00, including ~$5.85 net unfavorable items.
- Adjusted EPS guidance unchanged at $34.15-$34.85.
- Benefit expense ratio guidance reaffirmed at 89.1% ± 50 bps.
- Company expects 60% of adjusted EPS to be realized in first half of 2025.
- Officers reiterate guidance during investor meetings this week.

## SEC filing metadata
- accession: 0001156039-25-000096
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2025-05-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000115603925000096/0001156039-25-000096-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000115603925000096/elv-20250528.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001156039-25-000096
- JSON: https://secwatch.observer/filing/0001156039-25-000096.json
- Plain text: https://secwatch.observer/filing/0001156039-25-000096.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.